Regeneron Pharmaceuticals
REGN
#117
Rank
A$190.63 B
Marketcap
$1,729
Share price
-0.03%
Change (1 day)
35.05%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $56.18

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $56.04. In 2022 the company made an earnings per share (EPS) of $60.78 a decrease over its 2021 EPS that were of $114.67.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$56.18-7.56%
2022$60.78-47%
2021$114.67133.36%
2020$49.1469.13%
2019$29.05-14.44%
2018$33.96100.71%
2017$16.9231.78%
2016$12.8438.96%
2015$9.2472.55%
2014$5.35-17.55%
2013$6.49-44.98%
2012$11.80-422.54%
2011-$3.6692.13%
2010-$1.9049.41%
2009-$1.27-15.84%
2008-$1.51-36.88%
2007-$2.40-9.6%
2006-$2.654.12%
2005-$2.55-323.68%
2004$1.14-135.51%
2003-$3.21-24.38%
2002-$4.2456.35%
2001-$2.71187.3%
2000-$0.94-16%
1999-$1.12177.78%
1998-$0.40-35.71%
1997-$0.63-68.42%
1996-$1.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$21.22-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.16-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$27.69-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.13-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.61-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$4.77-91.49%๐Ÿ‡ซ๐Ÿ‡ท France